Paion AG Performance
| PAIOFDelisted Stock | USD 0.02 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Paion AG are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Paion AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Paion AG is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 19.7 M | |
| Total Cashflows From Investing Activities | -19.2 M |
Paion |
Paion AG Relative Risk vs. Return Landscape
If you would invest 2.00 in Paion AG on September 27, 2025 and sell it today you would earn a total of 0.00 from holding Paion AG or generate 0.0% return on investment over 90 days. Paion AG is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Paion, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Paion AG Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Paion AG's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Paion AG, and traders can use it to determine the average amount a Paion AG's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PAIOF |
Based on monthly moving average Paion AG is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Paion AG by adding Paion AG to a well-diversified portfolio.
Paion AG Fundamentals Growth
Paion Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Paion AG, and Paion AG fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Paion Pink Sheet performance.
| Return On Equity | -0.0965 | |||
| Return On Asset | -0.033 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.11) % | |||
| Current Valuation | 67.38 M | |||
| Shares Outstanding | 71.34 M | |||
| Price To Earning | 20.83 X | |||
| Price To Book | 3.01 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 7.13 M | |||
| EBITDA | (18.82 M) | |||
| Cash And Equivalents | 17.69 M | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 18.2 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.24 X | |||
| Cash Flow From Operations | (21.18 M) | |||
| Earnings Per Share | (0.33) X | |||
| Total Asset | 36.78 M | |||
About Paion AG Performance
By analyzing Paion AG's fundamental ratios, stakeholders can gain valuable insights into Paion AG's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Paion AG has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Paion AG has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. Paion AG was founded in 2000 and is based in Aachen, Germany. Paion Ag operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 64 people.Things to note about Paion AG performance evaluation
Checking the ongoing alerts about Paion AG for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Paion AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Paion AG is not yet fully synchronised with the market data | |
| Paion AG has some characteristics of a very speculative penny stock | |
| Paion AG has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 7.13 M. Net Loss for the year was (21.79 M) with profit before overhead, payroll, taxes, and interest of 4.05 M. | |
| Paion AG has accumulated about 17.69 M in cash with (21.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Theres trouble ahead for stocks and gold, according to these indicators - MarketWatch |
- Analyzing Paion AG's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Paion AG's stock is overvalued or undervalued compared to its peers.
- Examining Paion AG's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Paion AG's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Paion AG's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Paion AG's pink sheet. These opinions can provide insight into Paion AG's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Paion Pink Sheet
If you are still planning to invest in Paion AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paion AG's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |